EUVIMEDEUVIMED entdecken
Crossref

Amniotic fluid stem cell therapy improves erectile function in a diabetic rat model

Weerayut Wiriyabanditkul, Guiting Lin, Majken Højrup Wiborg, Xianghu Meng, Caipeng Qin, Lia Banie, Guifang Wang, Tom F Lue

Andrology · 2026-02 · 14 (2) · 603-610

DOI: 10.1111/andr.70117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Andrology, online erschienen am 05.09.2025. Verfasst von Weerayut Wiriyabanditkul und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Knuppe Molecular Urology Laboratory, School of Medicine, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Amniotic Fluid, Diabetes Mellitus, Experimental, Erectile Dysfunction, Stem Cell Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: California Urological Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current treatments for diabetic erectile dysfunction, such as phosphodiesterase type 5 inhibitors, penile injection, or vacuum erection devices, primarily offer symptomatic relief and do not address the underlying pathophysiology, which involves neural, vascular, and smooth muscle degeneration.

Objectives

This study aimed to evaluate the therapeutic potential of amniotic fluid‐derived stem cells in a rat model of diabetic erectile dysfunction by assessing their impact on erectile function and penile tissue regeneration.

Methods

Male Sprague‒Dawley rats were divided into control, diabetic, and amniotic fluid‐derived stem cell‐treated diabetic groups. Diabetes was induced using streptozotocin (60 mg/kg). Five weeks after intracavernous injection of amniotic fluid‐derived stem cells (1 × 10 6 cells per rat), erectile function, penile nerves, endothelial cells, and smooth muscle cells were evaluated through intracavernous pressure measurements, histological analyses, and cellular senescence assessments using class III β‐tubulin (TUBB3), rat endothelial cell antigen, and α‐smooth muscle actin markers, respectively, along with β‐galactosidase staining.

Results

Amniotic fluid‐derived stem cell treatment significantly improved erectile function in diabetic rats, as evidenced by increased intracavernous pressure/mean arterial pressure ratios than untreated diabetic rats ( p = 0.0307). Immunofluorescence revealed restoration of neuronal and endothelial markers, while α‐smooth muscle actin expression increased and β‐galactosidase activity decreased, indicating enhanced smooth muscle integrity and reduced cellular senescence.

Conclusion

Intracavernous amniotic fluid‐derived stem cell therapy effectively restores erectile function and mitigates tissue damage in diabetic rats by promoting neurovascular regeneration and reducing senescence, highlighting amniotic fluid‐derived stem cells as a promising regenerative therapy for diabetic erectile dysfunction and supporting further pre‐clinical and clinical investigations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amniotic FluidDiabetes Mellitus, ExperimentalErectile DysfunctionStem Cell TransplantationPenile ErectionAnimalsMaleRats, Sprague-DawleyRatsPenisDisease Models, Animal

Stichwörter der Autor:innen

amniotic fluid‐derived stem cells (AFSCs)diabetic ED (DMED)intracavernous pressure (ICP)mechanismtreatment

Autor:innen und Institutionen

  • Department of Urology, Knuppe Molecular Urology Laboratory, School of Medicine, University of California, San Francisco, California, USA.
  • Department of Surgery, Division of Urology, Phramongkutklao Hospital, Bangkok, Thailand.
  • Klinik for Sexologi, Esbjerg, Denmark.

Förderung

  • California Urological Foundation

Zitieren

APA

Wiriyabanditkul, W., Lin, G., Wiborg, M. H., Meng, X., Qin, C., Banie, L., Wang, G., & Lue, T. F. (2026). Amniotic fluid stem cell therapy improves erectile function in a diabetic rat model. Andrology, 14(2), 603-610. https://doi.org/10.1111/andr.70117

Vancouver

Wiriyabanditkul W, Lin G, Wiborg MH, Meng X, Qin C, Banie L, et al. Amniotic fluid stem cell therapy improves erectile function in a diabetic rat model. Andrology. 2026;14(2):603-610. doi:10.1111/andr.70117

BibTeX
@article{Wiriyabanditkul2026,
  author = {Wiriyabanditkul, Weerayut and Lin, Guiting and Wiborg, Majken Højrup and Meng, Xianghu and Qin, Caipeng and Banie, Lia and Wang, Guifang and Lue, Tom F},
  title = {Amniotic fluid stem cell therapy improves erectile function in a diabetic rat model},
  journal = {Andrology},
  year = {2026},
  volume = {14},
  number = {2},
  pages = {603--610},
  doi = {10.1111/andr.70117}
}
Kostenlos starten →